Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant I-131 Lipiodol for HCC Recurrence
NCT00870558Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2005
- Primary completion
- May 2011
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 3 trial of iodine-131-labeled lipiodol in hepatocellular carcinoma (HCC), sponsored by Hospices Civils de Lyon. Started Jun 2005; status: completed.
02
Drugs
iodine-131-labeled lipiodol
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00870558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870558.